The complexity of the Belgian market is difficult to change. Progress is being made, but slower than we would like to see
In Conversation
Search by Country
Our major focus when creating Gynebio Pharma was creating a company and a production facility that would benefit Morocco, but also Africa and the Middle East;…
Merck is well-positioned to be a partner to the authorities in many ways including R&D, production, and technology integration
Comparing the Czech Republic with other markets in EE, I would say that the country provides a solid landscape for the introduction of new products and…
Romania needs to find alternative sources of funding and requires more effective management of the current budget
I believe Nordic Belgium can be a great role model for other countries on how to successfully leverage a country’s assets to bring new products to…
About 38.7 million adults between the ages of 20 to 79 [in the MENA region] are currently diabetic, which means that, by 2040, about 82 million…
The market being stagnant, prices are dropping and competition is rising. It is, therefore, crucial to define the right growth channel, such as exports, as Morocco…
Even though the consumption of medicines per capita [in Romania] is still lower than the European average, we are catching up
In the UAE and across the GCC, where NCDs represent a significant hurdle for the healthcare system, our strategy is to foster meaningful partnerships with the…
Increasingly, medicines are putting pressure on public funds, that is why companies must contribute to facilitating patient access to treatment in accordance with the applicable legislation
Accord provides one-third of the oncological treatments in Europe which makes it the continent's leading supplier of oncology products. In Romania, oncology and haematology are the…
